Pliant Therapeutics, Inc 10-Q for FY2020 Q2

Headline figures

Quarter ended June 30, 2020, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue

$3.6M

Net loss

$17M

compared with a net loss of $15.52M a year earlier

Diluted EPS

-$1.39

compared with -$10.82 a year earlier